Q3 2024 Presentation and Q&A
How does this Q&A work:
This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.
The company will address as many questions as possible, and focus on those questions most wanted by investors.
Speakers at this event:
9 Questions
Nov. 29, 2024
Your new Astrum 10-10 oil product is the best product for STENOCARE 3.0 – please explain the value proposition for this product?
Nov. 29, 2024
You listed the target markets for STENOCARE 3.0 – will you be expanding into more markets?
Nov. 29, 2024
What are the financial benefits from spinning-off the cultivation facility?
Nov. 29, 2024
This week the Danish Minister of Health announced a permanent legalization of medical cannabis. How will this impact your business?
Nov. 29, 2024
You also showed a continued reduction in expenses. What are the key drivers behind this?
Nov. 29, 2024
Your Q3 Report indicate a need for additional capital. Can you share some information about this?
Nov. 29, 2024
How will the news in Denmark affect you going forward, do you expect increasing demand, higher prices or how will it affect you?
Nov. 29, 2024
Can you put some more words to the 3.0 strategy, how will you grow revenue, how will you increase profitability, where will you focus and what is the target over the next 12 months and 3 years?
Nov. 29, 2024
Leaving the production business seems god for cash flow but what is your competitive advantage when turning into a complete trading company?